We examined the effect of okara on the prevention of obesity in mice. A modified AIN-76 diet with a high fat content (14.1% of crude fat) was used as a basal diet. Male ICR mice were fed ad libitum with the basal diet or a dried okara-supplemented basal diet (10, 20, or 40%) for 10 weeks. The okara intake dose-dependently suppressed the development of body weight and epididymal white adipose tissue (EWAT), and prevented an increase of plasma lipids, including total cholesterol, LDL cholesterol, and non-esterified fatty acid. The okara intake also prevented steatosis in the liver. Real-time RT-PCR revealed that the okara intake induced downregulation of the fatty acid synthetase gene and upregulation of the cholesterol 7 alpha-hydroxylase (CYP7A1) gene in the liver. We also found that the okara intake caused a marked reduction in the expression of leptin and TNF-alpha genes in EWAT. Our results suggest that okara is beneficial in preventing obesity.
Soybean, a legume, contains high-quality proteins, dietary fiber, and phytochemicals, all of which exert beneficial effects on human health. 1, 2) Soy protein has been especially well examined with regard to its implication in diseases mediated by lipid disorders and obesity. [1] [2] [3] [4] [5] Okara is the residue obtained from soybeans after extracting soymilk, and is also thought to contain beneficial health components. Okara has traditionally been used as a food for humans and animals and as a fertilizer, although its disposal has become a significant problem in recent years. 6) Attempts, therefore, are being made to find a use for this potentially beneficial extract, and many trials have been reported on its fermentation, [7] [8] [9] extraction, 10) and digestion. 11) However, the use of okara itself has yet to be examined in detail.
An increasing prevalence of obesity has recently been reported worldwide in both developed [12] [13] [14] and developing 15, 16) countries. Obesity can induce many serious health problems and appears to lessen life expectancy, 17, 18) and its prevention should therefore be a worldwide priority. Okara contains a large amount of crude fiber composed of cellulose, hemicellulose, and lignin, and about 25% soy protein. 6) A dietary fiber intake is generally known to result in body fat loss, 19, 20) and soy protein is also known to be effective in preventing obesity, [1] [2] [3] [4] [5] suggesting that okara would also exert a beneficial effect on preventing obesity and/or lipid disorders. The aim of this study, therefore, is to investigate the possible effects of an okara intake on the prevention of obesity.
Materials and Methods
Diets and animals. Dried okara was purchased from Mamehiko (Yokohama, Kanagawa, Japan). Its nutritional data were analyzed by Japan Food Research Center (Nagoya, Japan; analysis number 306080656-002). A modified AIN-76 diet with a high fat content (14.1% of crude fat) was used as the basal diet (CLEA Japan, Tokyo, Japan), its ingredients being shown in Table 1 . A dried okara-supplemented basal diet at a concentration of 10, 20, or 40% was used as the okara diet. A commercially purchased general diet (CE-2, CLEA Japan) was used to evaluate the efficacy of the induction of obesity with the basal diet. Nutritional data for the basal diet, okara diets, and dried okara are shown in Table 2 . Total calories were calculated according to the standard of nutrition indication announced by Ministry of Health, Labour and Welfare of Japan (2003). Six-week-old male mice (ICR strain) were purchased from CLEA Japan. They were randomly assigned to 5 groups (6 mice per group), housed individually and fed on one of the foregoing diets ad libitum for 10 weeks. The mice fed on the basal diet are termed the control mice, those fed on the diet supplemented with 10, 20, or 40% dried okara as O-10, O-20, and O-40 mice, respectively, and those fed on the CE-2 diet as the CE-2 mice. After anesthetization with CO 2 gas without fasting, the mice were sacrificed and all organs were dissected for analysis. All experiments were performed in conformity with the International Guiding Principles for Biomedical Research Involving Animals. 21) Blood chemistry. The plasma total cholesterol, lowdensity lipoprotein (LDL) cholesterol, non-esterified fatty acid (NEFA), and triglyceride concentrations were respectively analyzed by using cholesterol E, LDL-C, NEFA-C, and triglyceride-E kits (Wako Pure Chemicals, Osaka, Japan).
Morphological analysis. The dissected liver samples were fixed overnight at 4 C with 4% paraformaldehyde in a 0.1 M sodium-phosphate buffer (pH 7.4) (PB), before being immersed in phosphate-buffered saline (PBS) containing 20% sucrose for 24 h at 4 C. The fixed liver samples were embedded in TISSU MOUNT (Shiraimatsukiki, Osaka, Japan) and quickly frozen with liquid nitrogen. Frozen sections (7 mm thick) were prepared with a cryostat, and then fixed with 4% paraformaldehyde in PB for 20 min at room temperature. After rinsing the fixed sections in PBS, hematoxylin (Mayer's Hematoxylin, Merck, Darmstadt, Germany) and eosin (Eosin Y, Merck) staining (HE staining) was carried out for microscopic observation with a BX-51 microscope (Olympus, Tokyo, Japan).
Oil red O staining for neutral lipid detection in the liver tissues. Sections prepared as for the morphological analysis were immersed in 60% isopropanol for 1 min, before being stained with 0.05% oil red O (Merck) in 60% isopropanol for 20 min at 37 C. The sections were briefly washed in 60% isopropanol and then rinsed in distilled water. After hematoxylin staining of the nucleic counters, the stained sections were observed with the BX-51 microscope (Olympus).
Quantitative real-time RT-PCR. RNA extraction, cDNA synthesis and SYBR Green-based real-time PCR were conducted as previously described by Matsumoto et al. 22) Briefly, total RNA samples were isolated with a QuickPrep Total RNA extraction kit (GE Healthcare Bio-science, Piscataway, NJ, USA) from liver tissues or with an RNeasy lipid tissue kit (QIAGEN, Cambridge, MA, USA) from epididymal white adipose tissues according to the manufacturer's instructions. To prepare cDNA, one microgram of each total RNA sample was reverse-transcribed by using Super Script III Rnase H À reverse transcriptase (Invitrogen, Carlsbad, CA, USA) and an oligo(dT) primer (Invitrogen). The prepared cDNA samples were purified with a PCR Purification Kit (QIAGEN).
Quantitative real-time PCR was performed on a BioFlux LineGene (TOYOBO, Osaka, Japan), using a SYBR Green Real-time PCR Master Mix (TOYOBO) according to the manufacturer's instructions. The housekeeping transcript, elongation factor-1 (EF-1), was used as an internal control because of its stable expression in vivo.
23) The primers used for each gene are summarized in Table 3 . The PCR products were evaluated by inspecting their melting curves (data not shown).
Statistics. A statistical analysis was conducted by oneway ANOVA and Fisher's PLSD test with Stat View software (SAS Institute, Cary, NC, USA). 
Results
Effect of the okara diet on the body and internal organ weights
All animals treated with the okara diets were in good health throughout the experiment, and no side effects such as diarrhea were apparent (data not shown).
To examine the effect of okara on the prevention of obesity, we fed the okara diet to ICR male mice for 10 weeks. Although there were some differences in the nutritional contents of the experimental diets (Table 2) , the average of the total energy intake during the experimental period was almost the same in all groups ( Table 4 ). The mice fed on the basal diet showed significantly greater body weight, body weight gain, and development of visceral white adipose tissues (WAT) than those fed on the commercially purchased CE-2 diet ( Table 4 ), indicating that this basal diet could induce obesity. The addition of dried okara to the basal diet prevented the development of excessive body weight in a dose-dependent manner (Fig. 1) . Although a slight effect was observed with the O-10 mice, the O-20 and O-40 mice showed a significant preventative effect. The final body weight of the O-20 and O-40 mice was about 15% lower (p < 0:01) than that of the control mice, and their final body weight gain was about 40% lower (p < 0:001) than that of the control mice (Table 4) . The intake of the okara diet also influenced the increase in various internal organ weights, including two different WAT depots (Table 4 ). The weight of epididymal WAT (EWAT) was markedly lower in the mice fed on the okara diets than on the control mice (O-20, p < 0:05; O-40, p < 0:01). Moreover, although the difference was not statistically significant, dried okara intake also tended to prevent the development of retroperitoneal WAT (RWAT) behind the kidneys. These results suggest that the total visceral WAT depots were dose-dependently and markedly less in the mice fed on the okara diets than in the control mice. In addition, the preventative effect on the increase in weight was particularly notable in the liver. The liver weights of all mice fed on the okara diets, even the O-10 mice, were statistically lower than those of the control mice (O-10, p < 0:01; O-20, p < 0:05; O-40, p < 0:001). On the other hand, no difference was apparent in kidney weight among the control mice and the mice fed on the okara diet, indicating that the difference in weight was presumably specific to the liver.
Histopathology of the liver
To identify the pathological basis for the difference in liver weight, we performed HE staining of the liver tissues of the mice tested (Fig. 2) . No fibrosis or inflammation was apparent in any of the mice, but hepatocytes of the control mice were rich in unstained cytoplasm ( Fig. 2A) . Unstained cytoplasmic regions were less in the O-10 and O-20 mice (Fig. 2B and C) , and scarcely apparent in the O-40 mice (Fig. 2D) . We further performed Oil red O staining, which is a staining method used for neural lipid detection, 24) of the liver tissues ( Fig. 3A-H) . Many lipid droplets were apparent in the control mice ( Fig. 3A and B ), but were far fewer in the O-10 and O-20 mice (Fig. 3C-F) . No lipid droplets were apparent in the liver of the O-40 mice ( Fig. 3G and H) . These results indicate that the difference in liver weight was due to the development of fatty liver.
To examine the alteration in synthesis of fatty acid in the liver, we carried out real-time RT-PCR of the fatty acid synthase (FAS) gene which regulates lipogenesis and adipocyte differentiation (Fig. 3I) . 25) Although the difference was not statistically significant, FAS expression in the O-10 and O-20 mice was about 30% lower than that in the control mice. Moreover, the expression level in the O-40 mice was significantly lower at about 40% of the level in the control mice (p < 0:001).
Prevention of elavated plasma lipids by the okara intake
To investigate the effect on plasma lipid disorders, we examined the concentrations of plasma total cholesterol, LDL cholesterol, NEFA, and triglyceride (Fig 4) , increases of which level lead to lipid disorders. Since the plasma samples were prepared from the mice without any fasting, some scatter were apparent in the data, especially in the triglyceride concentration. Total cholesterol, LDL cholesterol, and NEFA tended to be suppressed by the okara intake in a dose-dependent manner (Fig. 4A, B and C) . Although there was no dosedependence, triglyceride was also significantly suppressed in the O-40 mice (p < 0:05, Fig. 4D ).
Cholesterol biosynthesis and the conversion of cholesterol to bile acids in the liver play important roles in whole body cholesterol homeostasis. 26, 27) To examine the effect of an okara intake on cholesterol homeostasis, we carried out real-time RT-PCR in the liver tissues for HMG-CoA reductase (HMGCR), the rate-limiting enzyme in cholesterol biosynthesis, 26) and cholesterol 7 alpha-hydroxylase (CYP7A1), the initial and ratelimiting enzyme in bile acid biosynthesis. 27) Although -1) , was used as a control to standardize the efficiency of each reaction. Each result is the mean AE SE (n ¼ 6).
Ã P < 0:01 compared with control mice.
the HMGCR gene expression was not changed, the CYP7A1 gene was dose-dependently up-regulated by the okara intake (O-40, p < 0:05) (Fig. 5A and B) .
Expression changes of adipocytokines in EWAT
Adipocytokines are bio-active substances secreted from adipocytes, 28) secretion disorders of which have been reported with obesity and obesity-related diseases; for example, hypersecretion of leptin and tumor necrosis factor (TNF)-and hyposecretion of adiponectin. [28] [29] [30] We therefore examined their gene expression in EWAT by using real-time RT-PCR (Fig. 6) . Although there was no difference in adiponectin expression (Fig. 6B) , the okara intake significantly suppressed the expression of leptin (O-10, p < 0:05; O-20 and O-40, p < 0:005; 
Discussion
Soybean has become noteworthy in recent years because of its anti-obesity property, and many studies have been reported on the beneficial components of soybean such as protein, phytochemicals, and peptides. [1] [2] [3] [4] [5] Merritt has reviewed the beneficial effects of soy protein and soybean phytoestrogens on the prevention of metabolic syndrome, 2) in which visceral white adipose tissue accumulation has been shown to play a crucial role in the development of cardiovascular disease and in the development of obesity-related disorders such as diabetes mellitus, hyperlipidemia and hypertension. 31) Its residue, okara, also contains these components, and we have shown here the beneficial effects of an okara intake on the prevention of obesity, hepatocyte steatosis, and lipid disorders by using a mice model.
As shown in Table 2 , dried okara contains 24% protein which corresponds to about 70% of the soybean protein content, indicating that the beneficial properties of soy protein can also be expected with okara. Ascencio et al. have reported that the replacement of casein with soy protein prevented fatty liver, reduced the hepatic FAS gene expression, and up-regulated the hepatic CYP7A1 gene. 32) These effects were actually observed from the okara intake in this study. We also found that Elongation factor-1 (EF-1) was used as a control to standardize the efficiency of each reaction. Each result is the mean AE SE (n ¼ 6).
Ã P < 0:05 compared with control mice.
the okara intake suppressed the development of visceral white adipose tissues and reduced the leptin gene expression in EWAT. The main effect of leptin is the regulation of energy homeostasis, and leptin in the circulating serum is usually proportional to the total adipose tissue mass. 30) Tovar et al. have indicated that dietary soy protein promoted the conversion of large adipocytes to smaller ones, 33) suggesting that the soy protein in okara might have affected the development of adipose tissues and the expression of the leptin gene. In addition, okara is rich in dietary fiber.
6) It has been reported that some types of dietary fiber exerted a serum cholesterol-lowering effect by increasing fecal bile acid excretion. [34] [35] [36] An increase in fecal bile acid excretion induces the conversion of cholesterol to bile acids, resulting in a decrease in the serum cholesterol level. Conversion of cholesterol to bile acids therefore plays an important role in cholesterol homeostasis. 27) We have demonstrated in this study a dose-dependent increase in CYP7A1, the initial and rate-limiting enzyme on the bile acid biosynthetic pathway, resulting from the okara intake, suggesting that the dietary fiber in okara might accelerate fecal bile acid excretion and the subsequent increase in conversion of cholesterol to bile acid, finally resulting in a decrease in the plasma cholesterol levels.
Epidemiological studies also support a dietary fiber intake preventing obesity, and a fiber intake is known to be inversely associated with body weight and body fat. 19, 20) Although the functional constituents were not revealed in this study, one or more components in okara, including soy protein and dietary fiber, may have exerted beneficial effects singly, synergistically, or additively. Therefore, okara also seems to be as beneficial as soybean.
The relationship between diet, gene expression, and health has recently been actively studied in what is called nutrigenomics. 37) Nutrigenomics has helped identify the evidence-based relevance of functional food and promote an increased understanding of how nutrition influences health control. We investigated here the expression changes in genes related to fatty acid synthesis and obesity in the liver and EWAT, and revealed that an okara intake suppressed gene expression of FAS in the liver and of leptin and TNF-in EWAT. We also detected up-regulation of the CYP7A1 gene in the liver. Moreover, these genetic changes were closely correlated with pathological features. The expression of FAS was correlated with an accumulation of lipids in the liver, and that of leptin was correlated with the amount of visceral WAT. FAS is known to regulate fatty acid synthesis and lipogenesis, 25) and the FAS pathway could be a common molecular target for central appetitive and peripheral metabolic regulation. 38) On the other hand, TNF-has been implicated in insulin resistance, 39) indicating that an okara intake may also lead to the prevention of insulin resistance. Although a decrease of adiponectin in WAT has been reported with obesity, 28, 30) the okara intake did not influence adiponectin gene expression in EWAT. These results indicate the antiobesity effect of the okara intake from a nutrigenomic point of view. However, further studies on the protein level and enzymatic activities are required to explore the effect of the okara intake and are in current progress in our laboratory.
In conclusion, we have shown in the present study that okara was beneficial for the prevention of obesity, hepatocyte steatosis, and lipid disorders. Our results might lead to the inclusion of okara in our diet, benefiting human health as well as the ecological problem of its disposal. Elongation factor-1 (EF-1) was used as a control to standardize the efficiency of each reaction. Each result is the mean AE SE (n ¼ 6).
Ã P < 0:05, ÃÃ P < 0:005 compared with control mice.
